SC 13D
SC 13D Filing
- Company
- Pyxis Oncology, Inc.
- Filed
- October 22, 2021
- Accession Number
- 0000905148-21-000683
A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →